PMID- 38021644 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231201 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 15 IP - 10 DP - 2023 Oct TI - The Hidden Threat: Endocrine Disruptors and Their Impact on Insulin Resistance. PG - e47282 LID - 10.7759/cureus.47282 [doi] LID - e47282 AB - The association between Insulin resistance, a global health issue, and endocrine disruptors (EDCs), chemicals interfering with the endocrine system, has sparked concern in the scientific community. This article provides a comprehensive review of the existing literature regarding the intricate relationship between EDCs and insulin resistance. Phthalates, commonly found in consumer products, are well-established EDCs with documented effects on insulin-signaling pathways and metabolic processes. Epidemiological studies have connected phthalate exposure to an increased risk of type 2 diabetes mellitus (T2DM). Perfluoroalkyl substances (PFAS), persistent synthetic compounds, have shown inconsistent associations with T2DM in epidemiological research. However, studies suggest that PFAS may influence insulin resistance and overall metabolic health, with varying effects depending on specific PFAS molecules and study populations. Bisphenol A (BPA), found in plastics and resins, has emerged as a concern for glucose regulation and insulin resistance. Research has linked BPA exposure to T2DM, altered insulin release, obesity, and changes in the mass and function of insulin-secreting beta-cells. Triclosan, an antibacterial agent in personal care products, exhibits gender-specific associations with T2DM risk. It may impact gut microbiota, thyroid hormones, obesity, and inflammation, raising concerns about its effects on metabolic health. Furthermore, environmental EDCs like polycyclic aromatic hydrocarbons, pesticides, and heavy metals have demonstrated associations with T2DM, insulin resistance, hypertension, and obesity. Occupational exposure to specific pesticides and heavy metals has been linked to metabolic abnormalities. CI - Copyright (c) 2023, Dagar et al. FAU - Dagar, Mehak AU - Dagar M AD - Internal Medicine, Himalayan Institute of Medical Sciences, New Delhi, IND. FAU - Kumari, Priya AU - Kumari P AD - Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK. FAU - Mirza, Agha Muhammad Wali AU - Mirza AMW AD - Internal Medicine, Jinnah Medical and Dental College, Karachi, PAK. FAU - Singh, Shivani AU - Singh S AD - Medicine, MediCiti Institute of Medical Sciences, Hyderabad, IND. FAU - Ain, Noor U AU - Ain NU AD - Medicine, Mayo Hospital, Lahore, PAK. AD - Medicine, King Edward Medical University, Lahore, PAK. FAU - Munir, Zainab AU - Munir Z AD - Emergency Department, Imran Idrees Teaching Hospital, Sialkot, PAK. FAU - Javed, Tamleel AU - Javed T AD - Emergency Department, Imran Idrees Teaching Hospital, Sialkot, PAK. FAU - Virk, Muhammad Furqan Ismat AU - Virk MFI AD - Paediatrics, ABWA Hospital and Research Centre, Faisalabad, PAK. FAU - Javed, Saleha AU - Javed S AD - Emergency Department, Sheikh Zayed Hospital, Rahim Yar Khan, PAK. FAU - Qizilbash, Farwa Haider AU - Qizilbash FH AD - Medicine, Dow Medical College and Civil Hospital, Karachi, PAK. FAU - Kc, Anil AU - Kc A AD - Medicine and Surgery, Patan Academy of Health Sciences, Kathmandu, NPL. AD - Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA. FAU - Ekhator, Chukwuyem AU - Ekhator C AD - Neuro-Oncology, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, USA. FAU - Bellegarde, Sophia B AU - Bellegarde SB AD - Pathology and Laboratory Medicine, American University of Antigua, Coolidge, ATG. LA - eng PT - Journal Article PT - Review DEP - 20231018 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC10656111 OTO - NOTNLM OT - bisphenol a OT - endocrine disruptors OT - environmental endocrine-disrupting chemicals OT - heavy metals OT - insulin resistance OT - perfluoroalkyl substances OT - pesticides OT - phthalates OT - polycyclic aromatic hydrocarbons OT - triclosan COIS- The authors have declared that no competing interests exist. EDAT- 2023/11/29 18:42 MHDA- 2023/11/29 18:43 PMCR- 2023/10/18 CRDT- 2023/11/29 15:09 PHST- 2023/10/17 00:00 [accepted] PHST- 2023/11/29 18:43 [medline] PHST- 2023/11/29 18:42 [pubmed] PHST- 2023/11/29 15:09 [entrez] PHST- 2023/10/18 00:00 [pmc-release] AID - 10.7759/cureus.47282 [doi] PST - epublish SO - Cureus. 2023 Oct 18;15(10):e47282. doi: 10.7759/cureus.47282. eCollection 2023 Oct.